Technological watch

Kiefel Packaging to show future proof performance tool at K2019

“The next generation thermoforming machines has improved significantly in both performance and efficiency. The cyclespeed of the new KTR 5.2 for instance, can be up to 50 cycles per minute. Innovative thermoforming machines like this need a tool that is optimally designed to handle these kind of specifications.”, says Arjan Bogers, Technical Director of Kiefel Packaging. “Our new performance tool is equipped to meet and even exceed all expectations. Obviously it is a perfect fit for the new KTR5.2. Speed Cup-forming System from Kiefel, but the tool is equally available on all other major thermoforming systems”.

All innovations in one tool“We have a dedicated tool team, that together with our R&D department put all their effort in realizing continuous innovation for our customers. It is safe to say that for this project we have put 40 years of experience in thermoforming in one tool”. The tool consists of a steelbased tool construction with a lightweight design, resulting in a 15% weight reduction. An innovative cooling solution is integrated, designed to fit the requirements of high speed performance thermoforming machines. A new cutting punch technology is applied, using divided cutting punches. With its tight tolerances, a maximum cutting life time is guaranteed. The tool is equipped with Bosch SprangTM quick change tool parts for form inserts, ejector bases and plug assists. As the company stresses, there are more benefits that are integrated in itsfuture proof tool .

Circular EconomyThe new KTR5.2 tool fits perfectly in the sustainability vision of Kiefel Packaging.

In a circular economy approach, biobased materials like PLA or products made from 100% recycled material, demand different requirements from thermoform tooling. For instance, more cutting forces are needed when working with R-PET or PLA. The new tool is designed to match these demands. 

Publication date: 02/10/2019

Smart Extrusion



      

This project has received funding from the Bio Based Industries Joint Undertaking under the European Union’s Horizon 2020 research and innovation programme under grant agreement No 837761.